Literature DB >> 14726349

Glaucoma--2: treatment.

P T Khaw1, P Shah, A R Elkington.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726349      PMCID: PMC314518          DOI: 10.1136/bmj.328.7432.156

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Prescription of ocular beta-blockers in patients with obstructive pulmonary disease: Does a central electronic medical record make a difference?

Authors:  Shlomo Vinker; Igor Kaiserman; Dan Andrei Waitman; Shimon Blackman; Eliezer Kitai
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

2.  In vivo biocompatibility assessment of (PTFE-PVDF-PP) terpolymer-based membrane with potential application for glaucoma treatment.

Authors:  Rafał Leszczynski; Ewa Stodolak; Jarosław Wieczorek; Jolanta Orlowska-Heitzman; Teresa Gumula; Stanislaw Blazewicz
Journal:  J Mater Sci Mater Med       Date:  2010-07-23       Impact factor: 3.896

3.  Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial.

Authors:  Harvey B DuBiner; Douglas A Hubatsch
Journal:  BMC Ophthalmol       Date:  2014-11-28       Impact factor: 2.209

4.  Association between topical β-blocker use and asthma attacks in glaucoma patients with asthma: a cohort study using a claims database.

Authors:  Ai Kido; Masahiro Miyake; Tadamichi Akagi; Hanako Ohashi Ikeda; Takanori Kameda; Kenji Suda; Tomoko Hasegawa; Shusuke Hiragi; Satomi Yoshida; Akitaka Tsujikawa; Hiroshi Tamura; Koji Kawakami
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-09       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.